Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AS54
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 146 | 150 | PF00656 | 0.544 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.643 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.388 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.452 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 195 | 197 | PF00082 | 0.713 |
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.452 |
CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.635 |
CLV_PCSK_PC1ET2_1 | 195 | 197 | PF00082 | 0.713 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 278 | 282 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.468 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.457 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.540 |
DOC_MAPK_gen_1 | 227 | 236 | PF00069 | 0.602 |
DOC_MAPK_gen_1 | 276 | 283 | PF00069 | 0.533 |
DOC_MAPK_gen_1 | 54 | 61 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 108 | 115 | PF00069 | 0.467 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.763 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.523 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 183 | 187 | PF00917 | 0.695 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.584 |
DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.692 |
LIG_14-3-3_CanoR_1 | 11 | 16 | PF00244 | 0.398 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.514 |
LIG_FHA_1 | 258 | 264 | PF00498 | 0.584 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.546 |
LIG_FHA_2 | 209 | 215 | PF00498 | 0.488 |
LIG_Integrin_RGD_1 | 197 | 199 | PF01839 | 0.533 |
LIG_LIR_Gen_1 | 53 | 62 | PF02991 | 0.531 |
LIG_LIR_Nem_3 | 14 | 18 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 19 | 23 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.576 |
LIG_PCNA_yPIPBox_3 | 270 | 281 | PF02747 | 0.552 |
LIG_Pex14_2 | 126 | 130 | PF04695 | 0.592 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.467 |
LIG_SH2_GRB2like | 239 | 242 | PF00017 | 0.524 |
LIG_SH2_SRC | 239 | 242 | PF00017 | 0.524 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.409 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.536 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.595 |
LIG_SH3_3 | 95 | 101 | PF00018 | 0.734 |
LIG_TRAF2_1 | 107 | 110 | PF00917 | 0.611 |
LIG_TYR_ITIM | 18 | 23 | PF00017 | 0.469 |
LIG_UBA3_1 | 280 | 287 | PF00899 | 0.443 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.661 |
MOD_CK1_1 | 122 | 128 | PF00069 | 0.615 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.705 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.420 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.752 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.554 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.480 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.734 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.538 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.705 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.492 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.447 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.434 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.432 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.650 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.553 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.688 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.633 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.729 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.546 |
MOD_LATS_1 | 255 | 261 | PF00433 | 0.387 |
MOD_N-GLC_1 | 11 | 16 | PF02516 | 0.433 |
MOD_N-GLC_2 | 187 | 189 | PF02516 | 0.496 |
MOD_N-GLC_2 | 241 | 243 | PF02516 | 0.511 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.619 |
MOD_NEK2_2 | 163 | 168 | PF00069 | 0.544 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.523 |
MOD_Plk_1 | 11 | 17 | PF00069 | 0.476 |
MOD_Plk_1 | 132 | 138 | PF00069 | 0.537 |
MOD_Plk_1 | 163 | 169 | PF00069 | 0.544 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.582 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.584 |
MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.692 |
MOD_SUMO_for_1 | 130 | 133 | PF00179 | 0.560 |
MOD_SUMO_for_1 | 143 | 146 | PF00179 | 0.618 |
MOD_SUMO_for_1 | 29 | 32 | PF00179 | 0.435 |
MOD_SUMO_rev_2 | 85 | 93 | PF00179 | 0.479 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.469 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.466 |
TRG_ER_diArg_1 | 167 | 170 | PF00400 | 0.702 |
TRG_ER_diArg_1 | 54 | 56 | PF00400 | 0.446 |
TRG_ER_diLys_1 | 284 | 287 | PF00400 | 0.551 |
TRG_NLS_MonoExtC_3 | 167 | 172 | PF00514 | 0.643 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD46 | Leptomonas seymouri | 54% | 100% |
A0A3S7WVP3 | Leishmania donovani | 86% | 97% |
A0A422NC58 | Trypanosoma rangeli | 40% | 100% |
A4HA55 | Leishmania braziliensis | 75% | 99% |
A4HYC0 | Leishmania infantum | 86% | 97% |
D0A642 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
Q4QDB2 | Leishmania major | 82% | 99% |
V5BKZ5 | Trypanosoma cruzi | 39% | 100% |